Use of hyperbaric oxygen therapy of purpura... (2023 study) Skip to main content
Case Study Journal of neonatal-perinatal medicine 2023

Use of hyperbaric oxygen therapy of purpura fulminans in an extremely low birth weight preterm: A case report.

Yılmaz A, Kaya N, Meriç R, Bayramli Z, Öroğlu B, Celkan TT, et al., Journal of neonatal-perinatal medicine, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote up the case of an extremely low birth weight preterm infant who developed purpura fulminans, a rare and fatal skin and soft tissue condition, and who was treated with hyperbaric oxygen therapy (HBOT).

What They Found

This case report describes an extremely low birth weight preterm infant with purpura fulminans that started in the fingers of the right hand, and the abstract reports protein S deficiency plus homozygous MTHFR (A1298C) and Factor V Leiden (R506Q) mutations. The infant did not respond to fresh frozen plasma or unfractionated heparin. The authors then describe HBOT as a curative treatment and note it had not previously been used for this purpose in extremely low birth weight preterm infants. The abstract gives no outcome data, no HBOT pressure or session count, and no measured results.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a report of one infant with no comparison group, and the abstract provides no outcome measures, HBOT protocol details or follow-up, so it cannot show that HBOT caused any improvement.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Study
Category Infection
Source Pubmed
PubMed ID 32741781
Year Published 2023
Journal Journal of neonatal-perinatal medicine
MeSH Terms Infant; Humans; Infant, Newborn; Purpura Fulminans; Hyperbaric Oxygenation; Heparin; Infant, Extremely Low Birth Weight; Infant, Premature

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology